Cancer death rates drop 35% as research advances improve patient outcomes

Cancer deaths have decreased by 35% since 1991, saving millions of lives through research advancements. Dr. Jeffrey Rubin shares his personal journey of battling a high-risk precursor to multiple myeloma. By participating in a clinical trial involving the drug daratumumab, he successfully halted the disease's progression, highlighting the critical role of clinical trials and early detection.